Ergomed PLC (LON:ERGO) insider Lewis Cameron bought 10,910 shares of Ergomed stock in a transaction on Wednesday, February 12th. The stock was acquired at an average price of GBX 456 ($6.00) per share, for a total transaction of £49,749.60 ($65,442.78).
ERGO stock opened at GBX 454 ($5.97) on Friday. The company has a quick ratio of 1.71, a current ratio of 1.78 and a debt-to-equity ratio of 16.65. The business’s fifty day simple moving average is GBX 426.10 and its two-hundred day simple moving average is GBX 357.89. Ergomed PLC has a twelve month low of GBX 165 ($2.17) and a twelve month high of GBX 478 ($6.29). The firm has a market cap of $216.82 million and a price-to-earnings ratio of -73.23.
Ergomed Company Profile
Ergomed plc provides clinical research, and drug development and safety and medical information services in the United Kingdom and internationally. The company offers clinical development, trial management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies.
Featured Article: What is Depreciation?
Receive News & Ratings for Ergomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ergomed and related companies with MarketBeat.com's FREE daily email newsletter.